These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37897805)

  • 1. Implementing Nexobrid for Burn Debridement in a Major Italian Burn Center: A Retrospective Review of Patient Outcomes.
    Lombardo GAG; Ciancio F; Violini H; Sapuppo C; Zagami S; Vena A; Giardina M; Donia C; Ranno R
    J Burn Care Res; 2024 Mar; 45(2):432-437. PubMed ID: 37897805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries.
    Hasham S; Riyat H; Fletcher A; O'Boyle CP; Alexander S
    Scars Burn Heal; 2023; 9():20595131231168333. PubMed ID: 37124159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eschar removal by bromelain based enzymatic debridement (Nexobrid
    Hirche C; Citterio A; Hoeksema H; Koller J; Lehner M; Martinez JR; Monstrey S; Murray A; Plock JA; Sander F; Schulz A; Ziegler B; Kneser U
    Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes.
    Shoham Y; Gasteratos K; Singer AJ; Krieger Y; Silberstein E; Goverman J
    Int Wound J; 2023 Dec; 20(10):4364-4383. PubMed ID: 37455553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
    Korzeniowski T; Strużyna J; Chrapusta AM; Krajewski A; Kucharzewski M; Piorun K; Nowakowski J; Surowiecka A; Kozicka M; Torres K
    Med Sci Monit; 2022 Jan; 28():e935632. PubMed ID: 35064095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic debridement in critically injured burn patients - Our experience in the intensive care setting and during burn resuscitation.
    Bowers C; Randawa A; Sloan B; Anwar U; Phipps A; Muthayya P
    Burns; 2022 Jun; 48(4):846-859. PubMed ID: 34493422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helpful hints in deciding what and when to operate after enzymatic debridement.
    Claes KEY; De Decker I; Monstrey S; Shoham Y; Vyncke T; Depypere B; De Wolf E; Decuypere F; Lannau B; Hoeksema H
    Burns; 2023 Feb; 49(1):80-90. PubMed ID: 35177282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Enzymatic Burn Debridement: Results of the DETECT Multicenter Randomized Controlled Trial.
    Shoham Y; Rosenberg L; Hickerson W; Goverman J; Iyer N; Barrera-Oro J; Lipovy B; Monstrey S; Blome-Eberwein S; Wibbenmeyer LA; Scharpenberg M; Singer AJ
    J Burn Care Res; 2024 Mar; 45(2):297-307. PubMed ID: 37715999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian recommendations on enzymatic debridement in burn surgery.
    Ranno R; Vestita M; Maggio G; Verrienti P; Melandri D; Orlandi C; Perniciaro G; De Angelis A; D'Alessio R; Mataro I; Pagnozzi E; Alessandro G; Caleffi E; Di Lonardo A; Ciappi S; Palombo P; Posadinu MA; Stella M; Romeo M; Minic J; Governa M; Giudice G
    Burns; 2021 Mar; 47(2):408-416. PubMed ID: 32723513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic debridement for circumferential deep burns: the role of surgical escharotomy.
    Grünherz L; Michienzi R; Schaller C; Rittirsch D; Uyulmaz S; Kim BS; Giovanoli P; Lindenblatt N
    Burns; 2023 Mar; 49(2):304-309. PubMed ID: 36604280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®.
    Sharaf A; Muthayya P
    Burns; 2022 Nov; 48(7):1618-1625. PubMed ID: 34973852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic debridement: past, present, and future.
    De Decker I; De Graeve L; Hoeksema H; Monstrey S; Verbelen J; De Coninck P; Vanlerberghe E; Claes KEY
    Acta Chir Belg; 2022 Aug; 122(4):279-295. PubMed ID: 35440290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U
    Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R
    Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Value of Debriding Enzymes as an Adjunct to Standard Early Surgical Excision in Human Burns: A Systematic Review.
    Salehi SH; Momeni M; Vahdani M; Moradi M
    J Burn Care Res; 2020 Nov; 41(6):1224-1230. PubMed ID: 32424404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cadaver model as a training tool for enzymatic burn debridement (Nexobrid®): A feasibility study.
    Wen J; Johnson K; O'Boyle CP
    Burns; 2022 Nov; 48(7):1706-1709. PubMed ID: 35210140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Single-Center Experience of Bromelain-Based Eschar Removal in Children with Mixed Deep Dermal and Full Thickness Burns.
    Korzeniowski T; Grywalska E; Strużyna J; Bugaj-Tobiasz M; Surowiecka A; Korona-Głowniak I; Staśkiewicz M; Torres K
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence.
    Loo YL; Goh BKL; Jeffery S
    J Burn Care Res; 2018 Oct; 39(6):932-938. PubMed ID: 29579268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
    Rosenberg L; Krieger Y; Bogdanov-Berezovski A; Silberstein E; Shoham Y; Singer AJ
    Burns; 2014 May; 40(3):466-74. PubMed ID: 24074719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity.
    Fischer S; Haug V; Diehm Y; Rhodius P; Cordts T; Schmidt VJ; Kotsougiani D; Horter J; Kneser U; Hirche C
    Surgery; 2019 Jun; 165(6):1100-1105. PubMed ID: 30678870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.